Analyst Price Targets — ACET
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| January 6, 2026 11:23 am | — | Canaccord Genuity | $18.00 | $8.15 | TheFly | Adicet Bio price target lowered to $18 from $128 at Canaccord |
| December 12, 2022 6:19 am | — | H.C. Wainwright | $608.00 | $276.32 | Benzinga | HC Wainwright & Co. Maintains Buy on Adicet Bio, Raises Price Target to $38 |
| March 4, 2022 12:00 am | Kelly Shi | Jefferies | $432.00 | $200.96 | Pulse 2.0 | Adicet Bio (ACET) Stock: Why The Price Increased Today |
Latest News for ACET
REDWOOD CITY, Calif.--(BUSINESS WIRE)--Adicet Bio, Inc. (Nasdaq: ACET), a clinical stage biotechnology company discovering and developing allogeneic gamma delta CAR-T cell and in vivo CAR-T therapies for autoimmune diseases, hematologic malignancies and solid tumors, today announced completion of the last patient visit for the planned Phase 1 safety and efficacy analysis of prulacabtagene leucel (prula-cel) in…
REDWOOD CITY, Calif.--(BUSINESS WIRE)--Adicet Bio, Inc. (Nasdaq: ACET), a clinical stage biotechnology company discovering and developing allogeneic gamma delta CAR T cell and in vivo CAR T therapies for autoimmune diseases, hematologic malignancies and solid tumors, today announced it granted an inducement award on August 31, 2026. One individual was hired by Adicet in August 2026 and granted new hire non-qualified…
REDWOOD CITY, Calif.--(BUSINESS WIRE)--Adicet Bio, Inc. (Nasdaq: ACET), a clinical stage biotechnology company discovering and developing allogeneic gamma delta CAR T cell and in vivo CAR T therapies for autoimmune diseases, hematologic malignancies and solid tumors, today announced that the U.S. Food and Drug Administration (FDA) has cleared the Company's Investigational New Drug (IND) application for ADI-212 for…
Adicet Bio advances prula-cel in autoimmune diseases while pursuing new opportunities in prostate cancer and in vivo CAR-T.
Here is how Adicet Bio, Inc. (ACET) and Agilent Technologies (A) have performed compared to their sector so far this year.
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
No Senate trades found for ACET.
U.S. House Trading
No House trades found for ACET.
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.